Granules India Ltd.

₹495.3

Granules India Ltd.

₹495.3

₹495.3

-1.9 (-0.38%) - 30 Jun 2025 04:26 PM

About Company

Granules India Limited is one of the vertically integrated, high-growth pharmaceutical manufacturing company in India. Based out of Hyderabad, India, it is into manufacturing Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediaries (PFIs) and Finished Dosages (FDs). The company’s product-focused, vertically integrated business model has created a leadership position in several generic drugs. It has a strong presence in ‘first line of defence’ products, including Paracetamol, Ibuprofen, Guaifenesin and Metformin.

Market Cap. ₹ 12,018 Cr.
52 Week - High/Low ₹ 721/422
P/E Ratio 37.72
P/B Ratio 3.88
Enterprise Value ₹ 12,060 Cr.
ROE % 15.08
RSI Value 43.39
EMA 50 502.42
EMA 200 515.52
Market Cap. ₹ 12,018 Cr.
52 Week - High/Low ₹ 721/422
P/E Ratio 24.03
P/B Ratio 3.74
Enterprise Value ₹ 12,132 Cr.
ROE % 13.46
RSI Value 43.39
EMA 50 502.42
EMA 200 515.52

Growth

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.